Summary: Duloxetine is a balanced selective serotonin and norepinephrine-reuptake inhibitor available in the United States for the treatment of major depressive disorder (MDD) and diabetic ...

Once a controversial European depression treatment that never made it to the U.S. | The treatment, which was once a Pfizer ...

President-elect Donald Trump's pick to lead the Department of Health and Human Services, Robert F. Kennedy Jr., has a lot of ...

Public health experts have expressed concerns that Donald Trump‘s Health Secretary nominee Robert F. Kennedy Jr., aka RFK Jr.

AXS-12 statistically significantly reduced the frequency of cataplexy attacks compared to placebo (p=0.017, primary endpoint) ...

Axsome Therapeutics has announced that its investigational narcolepsy therapy has met the primary endpoint in a Phase III ...

017). Topline results were announced from a phase 3 trial evaluating AXS-12 (reboxetine) in patients with narcolepsy. AXS-12 is an investigational highly selective potent norepinephrine reuptake ...